R&D and GMP-Grade Products for Your Cell & Gene Therapy
Cell and gene therapies (CGT) represent a revolutionary frontier in modern medicine, offering the potential to treat or cure diseases that are otherwise intractable by conventional therapies. These approaches modify or replace cells and genes to address the underlying causes of genetic, degenerative, and acquired diseases.
Success in these advanced therapies relies on robust, reliable, and regulatory-compliant products throughout the entire workflow. Our portfolio supports every stage of your CGT research and development, with a strong focus on GMP-grade solutions designed to ensure consistency, scalability, and safety.
Featured CGT Products
Play a crucial role in CGT by enabling the efficient isolation, purification, and manipulation of cells, nucleic acids, and proteins through specific surface functionalization and rapid magnetic separation.
These proteins are manufactured under strict quality controls to ensure batch-to-batch consistency, biological activity, and safety, supporting reliable and scalable therapeutic applications.
Humanized and GMP-ready antibodies designed for reliable cell separation and activation, ensuring high specificity, reduced immunogenicity, and compliance with regulatory standards.
Chemically defined, serum-free kits formulated to ensure reproducibility, scalability, and regulatory compliance while supporting optimal cell growth and viability.
Ready-to-use, GMP-compliant cryopreservation solutions designed to preserve the viability, recovery, and functionality of cells, supporting consistent performance in CGT applications.
Discover a comprehensive portfolio of CGT products and GMP-grade solutions, supporting every stage from research to clinical manufacturing with a focus on consistency, scalability, and regulatory compliance.